Harlem Biospace Fellows
Harlem Biospace Fellows are consultants to the community of companies here at Hb and they contribute to both the technical design of products and the creation of business strategy. The current group ranges from biotechnology undergraduate students eager to carry out routine work to experienced healthcare consultants and postdoctoral researchers who can bring valuable perspective to the table. In return Fellows are given access to training events and gain operational experience useful to finding a full-time opportunity in early stage biotech.
To become a Fellow, please email firstname.lastname@example.org and we will get back to you with any opportunities available.
The current cohort of Hb Fellows includes:
Shantenu Agarwal has been extensively involved with building startups and growing companies for the past five years. A bioengineer by training, Shantenu has co-founded a health tech startup, worked at two venture capital funds, and managed corporate business development in Asia Pacific. Additionally, he has experience in consulting pharmaceutical companies, negotiating contracts with insurance companies, and advising clients on FDA policies. Shantenu graduated from the University of Pennsylvania and is passionate about technology, healthcare, and innovation.
Haoqian Chen is a PhD candidate at Columbia University specializing in an interdisciplinary approach to immunoengineering for adoptive immunotherapy. Before starting her doctoral studies, she completed a research fellowship at the National Institute of Health planning a novel experimental therapy for patients with rare immune conditions. Additionally, Haoqian was a Princeton University fellow for global health challenges working in Nigeria to study factors influencing community uptake of ceramic water filters. She is passionate about translational research and commercialization of experimental treatment and life-saving engineering solutions to improve the human condition.
Jack Fischer is a biotechnology enthusiast combining a background in microbiology and business strategy. Jack is passionate about transitioning creative scientific discoveries to the market as a mechanism to solve health crises. He is a pre-doctoral researcher at Albert Einstein College of Medicine examining persistence in Mycobacterium tuberculosis. He graduated from Skidmore College with a dual B.A. in Integrative Biology and Management & Business. Outside of the lab, Jack can be found running through Central Park and performing improv theater.
Chirag Raval is an engineer and research scientist with applied experience in chemical and biological membrane separation devices, vascular biology, immunofluorescence, and public health. He applies his scientific and engineering background to aid in developing biotechnologies with life science start-up companies as a Fellow at Harlem Biospace. Chirag received his PhD in biomedical engineering from the Graduate Center of the City University of New York and his B.S. in chemical engineering from the University of Delaware in 2005.
Catherine Tang is currently an analyst at Deutsche Bank, where she focuses on healthcare mergers and acquisitions advisory. She has experience in acquisitions, divestitures, contingent value rights, licensing, company valuations and evaluation of strategic alternatives in development and commercial stage biopharmaceutical, medtech and healthcare IT companies. Previously, she held undergraduate research roles in genetics and biochemistry labs. Catherine received a B.A. in Biochemistry and a B.S. in Economics with a concentration in Finance from the University of Pennsylvania.
Kavitha Gnanasambandan is a creative problem solver interested in collaborating with experts from various fields to develop novel drugs for unmet medical needs. She is a Postdoctoral Scientist at the New York University School of Medicine. Here, she combines structural, computational, and biochemical tools to identify druggable surfaces on kinase targets for cancer therapy. Apart from research, Kavitha has developed business plans for start up companies during her internship at the NYU Office of Industrial Liaison. Kavitha obtained her PhD in Biochemistry and Molecular Biology from the University of Florida. She is excited about applying her scientific and analytical skills towards developing commercialization strategies for life science startups.
Ana Raquel Martins is a PhD candidate in Neuroscience at New York University, where she studies the effects of high stress situations in the brain. She specializes in recording neuronal activity changes brought about by activation of the brain’s stress centers. Before starting her research work at NYU, Raquel completed a PharmD in her home country, Portugal, where she proceeded to work as a pharmacist for 2 years. As a researcher and healthcare professional, Raquel is passionate about steering science innovation towards meaningful improvements in people’s lives.
Neha Nigam has a combination of both scientific knowledge and its commercial aspects. She is passionate about the applied aspects of innovative scientific discoveries. Her foundation in life sciences comes from her PhD in molecular biology from Vienna, Austria. Her Post doc work was also in the same field at UCL, Belgium. She was awarded with scholarships and fellowships throughout her study and presented her work at several international conferences. After that, she worked in the industry as an Analyst involved in competitive intelligence, strategic business analysis and commercialization of early innovations in several therapeutic areas. Neha is excited to apply her analytical, scientific and communications skills towards commercialization assessments and business plan formulation with life science start up companies. Neha loves to travel, meet new people and try different cuisines.
Doug MacPherson completed a BS degree in Biological Sciences from the University of Connecticut and spent a year as a research assistant for Yale School of Medicine, Department of Nephrology. At Yale, Doug worked on projects studying the effect of a specific protein produced by the kidney in pancreatic cancer, melanoma, and chronic kidney disease. Currently, Doug is a research assistant for CUNY Advanced Science Research Center. At the ASRC, Doug works with peptide-based gels which function as a synthetic extracellular matrix for three-dimensional cell culture. The gels also have possible therapeutic applications as tissue scaffolds for regenerative medicine.
Sarah Weber is currently an equity research analyst at Piper Jaffray, where she focuses on the Emerging Biopharma sector. She is passionate about contributing to the growing biotech sector right here in NYC and began volunteering at Harlem Biospace in 2015. Her past experience includes marketing consulting at an NYC start-up as well as clinical research in Crohn’s Disease at Boston Children’s Hospital. Sarah graduated from Williams College in 2011 with a BA in psychology and neuroscience.